Analysis of Serious Weight Gain in Patients Using Alectinib for ALK-Positive Lung Cancer-Reference-Cited by-同舟云学术

Analysis of Serious Weight Gain in Patients Using Alectinib for ALK-Positive Lung Cancer

Published:2023-08 Issue:8 Volume:18 Page:1017-1030
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

de Leeuw Simon P.^ORCID,Pruis Melinda A.,Sikkema Barend J.,Mohseni Mostafa,Veerman G. D. Marijn,Paats Marthe S.,Dumoulin Daphne W.,Smit Egbert F.,Schols Annemie M.W. J.,Mathijssen Ron H.J.,van Rossum Elisabeth F.C.,Dingemans Anne-Marie C.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference67 articles.

1. 1142P The influence of food with different fat concentrations on alectinib exposure: a randomized cross-over pharmacokinetic trial;Lanser;Ann Oncol,2022

2. Updated overall survival and final progression-free survival data for patients with treatment-naive advanced ALK-positive non-small-cell lung cancer in the ALEX study;Mok;Ann Oncol,2020

3. Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up;Hendriks;Ann Oncol,2023

4. The imperative for a new approach to toxicity analysis in oncology clinical trials;Thanarajasingam;JNCI J Natl Cancer Inst,2015

5. Alectinib versus crizotinib in untreated ALK-positive non-small-cell lung cancer;Peters;N Engl J Med,2017

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A pragmatic guide for management of adverse events associated with lorlatinib;Lung Cancer;2024-05

2. Weight gain in patients with RET aberrant cancers treated with brain penetrant RET selective inhibitors;Annals of Oncology;2023-10

3. Letter to Editor. Re “de Leeuw SP, et al. Analysis of Serious Weight Gain in Patients Using Alectinib for ALK Positive Lung Cancer,” Semaglutide a Potential Treatment for Serious Weight Gain From ALK Tyrosine Kinase Inhibitors?;Journal of Thoracic Oncology;2023-09

4. Approach to Alectinib-Induced Body Weight Gain in Patients With ALK+ Non–Small Lung Cancer;Journal of Thoracic Oncology;2023-09